HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹56 Cr | ₹72 Cr | ₹128 Cr | ₹24 Cr | ₹80 Cr |
What is the latest Long Term Provisions ratio of HIKAL ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹56 Cr |
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹128 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹80 Cr |
How is Long Term Provisions of HIKAL Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹56 Cr | -22.32 | |
| Mar2025 | ₹72 Cr | -44.07 | |
| Mar2024 | ₹128 Cr | 429.23 | |
| Mar2023 | ₹24 Cr | -69.56 | |
| Mar2022 | ₹80 Cr | - | |
Compare Long Term Provisions of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,601.0 Cr | 8.3% | -3.3% | -15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 8.3% |
-3.3% |
-15.7% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses